Search
Search Results
##search.searchResults.foundPlural##
-
TREATMENT OF ADVANCED SYSTEMIC MASTOCYTOSIS WITH MIDOSTAURIN: PRACTICAL GUIDANCE FOR OPTIMAL THERAPY AND MANAGEMENT Advanced systemic mastocytosis and midostaurin
1228PDF: 976HTML: 209 -
-
CMV IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
4783PDF: 1776HTML: 2704Untitled: 213 -
ARA-C, IDARUBICINE AND GENTUZUMAB OZOGAMICIN (AIM) AS SALVAGE TREATMENT IN ADVANCED ACUTE MYELOID LEUKEMIA PATIENTS
1671PDF: 801HTML: 934cover letter: 264 -
THERAPY-RELATED MYELOID NEOPLASMS: PREDISPOSITION AND CLONAL EVOLUTION T-AML predisposition
1326PDF: 821HTML: 127 -
A MULTICENTER EXPERIENCE FROM LEBANON IN CHILDHOOD AND ADOLESCENT ACUTE MYELOID LEUKEMIA:HIGH RATE OF EARLY DEATH IN CHILDHOOD ACUTE PROMYELOCYTIC LEUKEMIA.
2059PDF: 1112HTML: 7689cover letter paper final AML: 213 -
TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA WITH AIDA BASED REGIMEN
3865PDF: 751HTML: 1846 -
CHLORAMBUCIL PLUS RITUXIMAB AS FRONT-LINE THERAPY IN ELDERLY/UNFIT PATIENTS AFFECTED BY B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA: RESULTS OF A SINGLE-CENTRE EXPERIENCE.
3156PDF: 892HTML: 1530Fig.1 CHL-R paper: 212Fig 2 CHL-R paper: 234 -
DOWNREGULATION OF STEAROYL-COA DESATURASE 1 (SCD-1) PROMOTES RESISTANCE TO IMATINIB IN CHRONIC MYELOID LEUKEMIA Downregulation of Scd-1 in Chronic Myeloid Leukemia
1297PDF: 1192HTML: 445 -
WALDENSTROM’S MACROGLOBULINEMIA: AN UPDATE
7413PDF: 2414HTML: 1724Table 1.: 205Table 2.: 215Table 3.: 197Table 4.: 198 -
THE ROLE OF AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION IN FOLLICULAR LYMPHOMA IN THE NEW DRUGS ERA.
4035PDF: 1143HTML: 1933Fig.1: 217Fig. 2: 107Table 1: 201Table2: 218Table 3: 198 -
OUTCOME OF ANTIFUNGAL COMBINATION THERAPY FOR INVASIVE MOLD INFECTIONS IN HEMATOLOGICAL PATIENTS IS INDEPENDENT OF THE CHOSEN COMBINATION
1087PDF: 539HTML: 1689Figures: 165Fifures Sanz: 176tables Sanz: 180Untitled: 176 -
REAL-WORLD OUTCOME IN THE PRE-CAR-T ERA OF MYELOMA PATIENTS QUALIFYING FOR CAR-T CELL THERAPY Real-world Assessment of Myeloma Patients as Candidates for CAR-T Therapy
1555PDF: 599HTML: 187 -
OLDER ADULTS WITH PH NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA: A MONOCENTRIC EXPERIENCE ON CONSECUTIVE PATIENTS AGED MORE THAN 55 YEARS Older Adults with Ph Negative Acute Lymphoblastic Leukemia
1282PDF: 563Suppl. Files: 343HTML: 140 -
Treating relapsed/refractory acute myeloid leukemia with chidamide, fludarabine, cytarabine and granulocyte-colony stimulating factor with subsequent bridging to myeloablative allogeneic hematopoietic stem cell transplantation Treating relapsed/refractory acute myeloid leukemia with chidamide, fludarabine, cytarabine and G-CSF
1752PDF: 562HTML: 275 -
BONE MARROW MICROENVIRONMENT INVOLVEMENT IN T-MN: FOCUS ON MESENCHYMAL STEM CELLS MESENCHYMAL STEM CELL IN T-MN
1773PDF: 964HTML: 140 -
LOW INCIDENCE RATE OF OPPORTUNISTIC AND VIRAL INFECTIONS DURING IMATINIB TREATMENT IN CHRONIC MYELOID LEUKEMIA PATIENTS IN EARLY AND LATE CHRONIC PHASE
1612PDF: 794HTML: 853jdoe, table 2 infections CML .doc: 193jdoe, table 1 infections CML .doc: 180 -
NEW TREATMENTS FOR MYELODYSPLASTIC SYNDROMES
1959PDF: 742HTML: 694 -
THERAPY-RELATED MYELOID NEOPLASM IN NON-HODGKIN LYMPHOMA SURVIVORS
2563PDF: 734HTML: 2296 -
-
TREATMENT OF LOW-BLAST COUNT AML USING HYPOMETHYLATING AGENTS
4306PDF: 1754HTML: 1106 -
Invasive Pulmonary Aspergillosis in a Sickle Cell Patient Transplant Recipient: A Successful Treatment
1916PDF: 1094HTML: 1890Lung computed tomography CT scan image: 200 -
PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations
3534PDF: 2396HTML: 1455 -
HEPATITIS C VIRUS INFECTION AND LYMPHOMA
990PDF: 532HTML: 7808 -
HEPATITIS B AND C IN HEMATOPOIETIC STEM CELL TRANSPLANT
966PDF: 531HTML: 720







